Consolidated Income Statements - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015		Sep. 30, 2014
Net sales	$ 4,873	$ 5,905	$ 19,831		$ 22,557
Other income, net	98	364	552		749
Total	4,971	6,269	20,383		23,306
Cost of goods sold	3,084	3,698	11,703		13,350
Other operating charges	91	201	413		609
Selling, general and administrative expenses	1,046	1,157	3,540		3,833
Research and development expense	441	486	1,415		1,491
Interest expense	82	93	260	[1]	290
Employee separation / asset related charges, net	0	0	40		244
Total	4,744	5,635	17,371		19,817
Income from continuing operations before income taxes	227	634	3,012		3,489
Provision for income taxes on continuing operations	96	303	886		921
Income from continuing operations after taxes	131	331	2,126		2,568
Income from discontinued operations after taxes	104	103	89		385
Net income	235	434	2,215		2,953
Less: Net income attributable to noncontrolling interests	0	1	9		11
Net income attributable to DuPont	$ 235	$ 433	$ 2,206		$ 2,942
Basic earnings per share of common stock from continuing operations	$ 0.14	$ 0.36	$ 2.34		$ 2.78
Basic earnings per share of common stock from discontinued operations	0.12	0.11	0.10		0.42
Basic earnings per share of common stock	0.26	0.47	2.44		3.20
Diluted earnings per share of common stock from continuing operations	0.14	0.36	2.33		2.76
Diluted earnings per share of common stock from discontinued operations	0.12	0.11	0.10		0.42
Diluted earnings per share of common stock	0.26	0.47	2.43		3.17
Dividends per share of common stock	$ 0.38	$ 0.47	$ 1.34		$ 1.37

[1] Included transaction costs of $(20) in the nine months ended September 30, 2015, associated with the early retirement of debt exchanged for the notes received from Chemours in May 2015.